LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

Search

Omnicell Inc

Avatud

SektorTervishoid

32.77 2.34

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

32.02

Max

32.79

Põhinäitajad

By Trading Economics

Sissetulek

13M

5.6M

Müük

21M

291M

P/E

Sektori keskmine

66.18

35.724

Aktsiakasum

-0.151

Kasumimarginaal

1.941

Töötajad

3,650

EBITDA

42M

30M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+30.06% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

29. okt 2025

Turustatistika

By TradingEconomics

Turukapital

162M

1.5B

Eelmine avamishind

30.43

Eelmine sulgemishind

32.77

Uudiste sentiment

By Acuity

50%

50%

167 / 371 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

Omnicell Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

2. sept 2025, 23:07 UTC

Omandamised, ülevõtmised, äriostud

Broadwood Partners Plans to Vote Against Staar Sale to Alcon

2. sept 2025, 22:10 UTC

Suurimad hinnamuutused turgudel

Bruker Shares Fall on Convertible Share Offering Aimed at Debt Repayment

2. sept 2025, 21:47 UTC

Tulu

Alimentation Couche-Tard Logs Lower Profit, Revenue in 1Q

2. sept 2025, 16:52 UTC

Suurimad hinnamuutused turgudel

CleanCore Solutions Shares Drop After $175 Million Private Investment

2. sept 2025, 22:47 UTC

Market Talk

Google, Apple Can Grow AI Deal With Lawsuit Resolved -- Market Talk

2. sept 2025, 21:40 UTC

Omandamised, ülevõtmised, äriostud

Investors Have to Be Ready for State Capitalism. What Areas to Watch. -- Barrons.com

2. sept 2025, 21:07 UTC

Tulu

Couche-Tard 1Q U.S. Same-Store Merchandise Revenue Up 0.4% >ATD.T

2. sept 2025, 21:07 UTC

Tulu

Couche-Tard 1Q Canada Same-Store Merchandise Revenue Up 4.1% >ATD.T

2. sept 2025, 21:05 UTC

Tulu

Couche-Tard 1Q Rev $17.35B >ATD.T

2. sept 2025, 21:05 UTC

Tulu

Couche-Tard 1Q Adj EPS 78c >ATD.T

2. sept 2025, 21:05 UTC

Tulu

Couche-Tard 1Q EPS 82c >ATD.T

2. sept 2025, 21:05 UTC

Tulu

Couche-Tard 1Q Net $782.5M >ATD.T

2. sept 2025, 21:00 UTC

Market Talk

ESG Roundup: Market Talk

2. sept 2025, 20:53 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Knight-Swift Transportation Endorses Union Pacific, Norfolk Southern Merger -- Market Talk

2. sept 2025, 20:51 UTC

Omandamised, ülevõtmised, äriostud

Buffett Dislikes Breakup of Kraft Heinz. It's Been One of His Worst Investments. -- Barrons.com

2. sept 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

2. sept 2025, 20:27 UTC

Tulu

NIO Stock Rises After Second-Quarter Loss Narrows -- Barrons.com

2. sept 2025, 20:24 UTC

Omandamised, ülevõtmised, äriostud

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

2. sept 2025, 20:18 UTC

Omandamised, ülevõtmised, äriostud

Procter & Gamble Does Not Endorse Tutanota's Unsolicited Mini-Tender Offer >PG

2. sept 2025, 20:17 UTC

Omandamised, ülevõtmised, äriostud

Procter & Gamble: Tutanota Says It Expects to Extend Offer for Successive Periods of Up to 180 Days Until Market Price Exceeds Offer Price >PG

2. sept 2025, 20:16 UTC

Omandamised, ülevõtmised, äriostud

Procter & Gamble: 'Shareholders Who Tender Their Shrs in the Offer Will Receive a Below-Market Price' >PG

2. sept 2025, 20:16 UTC

Omandamised, ülevõtmised, äriostud

Procter & Gamble: Offer by Tutanota Is to Purchase Up to 500,000 Shrs at $128 Each

2. sept 2025, 20:15 UTC

Omandamised, ülevõtmised, äriostud

Procter & Gamble Has Been Notified of Unsolicited Mini-Tender Offer by Tutanota >PG

2. sept 2025, 19:55 UTC

Tulu

GM Had a Record Month of EV Sales. A 'Collapse' Is Coming. -- Barrons.com

2. sept 2025, 19:50 UTC

Omandamised, ülevõtmised, äriostud

Food Giants Are Struggling. Could Mergers, Spinoffs, and Activist Stakes Help? -- Barrons.com

2. sept 2025, 19:09 UTC

Market Talk

Oil Futures Gain on Geopolitical Premium -- Market Talk

2. sept 2025, 19:00 UTC

Market Talk

U.S. Natural Gas Futures Recover $3 Level -- Market Talk

2. sept 2025, 18:12 UTC

Market Talk

Gold Pushes To New Record -- Market Talk

2. sept 2025, 17:04 UTC

Market Talk

Philip Morris Riding Smoke-Free Products to Higher Margins -- Market Talk

2. sept 2025, 16:57 UTC

Omandamised, ülevõtmised, äriostud

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Omnicell Inc Prognoos

Hinnasiht

By TipRanks

30.06% tõus

12 kuu keskmine prognoos

Keskmine 41.75 USD  30.06%

Kõrge 55 USD

Madal 32 USD

Põhineb 6 Wall Streeti analüütiku instrumendi Omnicell Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

6 ratings

4

Osta

2

Hoia

0

Müü

Tehniline skoor

By Trading Central

24.23 / 30.44Toetus ja vastupanu

Lühikene perspektiiv

Strong Bearish Evidence

Keskpikk perspektiiv

Strong Bearish Evidence

Pikk perspektiiv

Bearish Evidence

Sentiment

By Acuity

167 / 371 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.